Cecilia Vistarini

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

Federico Piñero, Manuel Mendizábal, Ezequiel Ridruejo et al. · Liver International · 2019 · 89 citations · Full text

Medicine, Oncology, Pharmacology +15

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents

Manuel Mendizábal, Federico Piñero, Ezequiel Ridruejo et al. · Clinical Gastroenterology and Hepatology · 2020 · 72 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study

Sebastián Marciano, Leila Haddad, María Virginia Reggiardo et al. · Journal of Medical Virology · 2018 · 22 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Role of <scp>HLA</scp>‐<scp>DP</scp> and <scp>HLA</scp>‐<scp>DQ</scp> on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population

Julieta Trinks, Nao Nishida, María Laura Hulaniuk et al. · Liver International · 2017 · 19 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17